Skip to main content

The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers.

Tennstedt P, Köster P, Brüchmann A, Mirlacher M, Haese A, Steuber T, Sauter G, Huland H, Graefen M, Schlomm T, Minner S, Simon R

Publication: Int J Oncol (2012) • Vol 40 • Page 261-8PMID: 21956230View on PubMed

Purpose

The purpose of this paper was to determine the effects of scoring methods and the number of tissue microarray (TMA) cores analyzed on Ki67 and p53 immunostaining results in prostate cancer specimens.

Conclusion

Ki67 and p53 immunopositivity increased when the number of analyzable cores increased from 1 or 2 to 3. However, the associations of positive immunostaining to tumor phenotype and clinical prognosis were uninfluenced by evaluation of individual cores, averaging 3 cores, considering only the highest scoring core, or determining positivity based on at least 1 of 3 cores scored as positive.

Studies (1)

Purpose

The purpose of this study was to determine the effects of scoring methods and the number of TMA cores analyzed on Ki67 and p53 immunostaining results in prostate cancer specimens. The percentage of Ki67 immunostaining was evaluated based on multiple categories while p53 immunostaining was categorized as positive (>1% staining) or negative.

Summary of Findings

Core loss amounted to 1.9, 1.4, and 2.1% of cores for each of 3 TMAs initially containing 3,261 cores. Further, lack of adequate cancer cells was observed in 20.5, 35.0, and 30.5% of the cores for each of the 3 TMAs making them non-informative. The percentage of Ki67 immunopositive cells was linked to the number of analyzable cores. Cases with 3 analyzable cores showed an average of 5.3% Ki67 immunopositive cells while tumors with only 1 analyzable core had an average of 4.1% Ki67 immunopositive staining (p<0.0001). Further, a higher percentage of p53 positivity was observed among cases where 3 analyzable cores were available (3.8%) as opposed to just 1 or 2 cores (1.9%, p=0.003). When only tumors for which 3 informative cores existed were further analyzed, no differences in clinical significance of Ki67 immunostaining were observed when all 3 cores were averaged, when only the highest Ki67 score was considered, or when tumors were classified as positive when at least one core was scored as positive. Ki67 immunostaining was significantly related to biochemical tumor recurrence whether core scores were considered individually, 3 scores were averaged, or just the highest score was considered. Further, there were no differences in the relation of Ki67 immunostaining to biochemical tumor recurrence when levels were defined by quartiles (0-25%, 25-50%, 50-75%, 75-100%) or by arbitrary cutoffs (negative, <10%, 10-20%, 20-100%). p53 immunostaining was related to early prostate specific antigen (PSA) recurrence whether each TMA was considered individually or the tumor was classified as positive based on scoring of at least 1 of 3 cores as positive.
  • Biospecimens

    TissueProstate
  • Preservation Types

    Formalin
  • Diagnoses

    Normal
    NeoplasticCarcinoma
  • Platforms

    ProteinImmunohistochemistry
    ProteinTissue microarray
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen Aliquots and ComponentsAliquot size/volume
    1 core evaluated
    2 cores evaluated
    3 cores evaluated
    Tissue microarray SpecificData handling
    3 cores averaged
    Arbitrary cutoffs used for categorizing
    At least one positive core determined positivity
    Highest core score considered
    Individual cores considered
    Quartiles used for categorizing
    Immunohistochemistry SpecificTargeted peptide/protein
    Cytokeratins
    Ki67
    p53